| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2022 | 373.68% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
| 07/29/2021 | 57.89% | Canaccord Genuity | $8 → $3 | Downgrades | Buy → Hold |
| 04/19/2021 | 321.05% | Canaccord Genuity | $7 → $8 | Maintains | Buy |
| 04/15/2020 | 478.95% | Canaccord Genuity | $12 → $11 | Maintains | Buy |
| 12/11/2019 | — | Mackie Research | Upgrades | Hold → Buy |
What is the target price for Theratechnologies (THTX)?
The latest price target for Theratechnologies (NASDAQ: THTX) was reported by Cantor Fitzgerald on November 17, 2022. The analyst firm set a price target for $9.00 expecting THTX to rise to within 12 months (a possible 373.68% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Theratechnologies (THTX)?
The latest analyst rating for Theratechnologies (NASDAQ: THTX) was provided by Cantor Fitzgerald, and Theratechnologies initiated their overweight rating.
When is the next analyst rating going to be posted or updated for Theratechnologies (THTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Theratechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Theratechnologies was filed on November 17, 2022 so you should expect the next rating to be made available sometime around November 17, 2023.
Is the Analyst Rating Theratechnologies (THTX) correct?
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a initiated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $1.90, which is within the analyst's predicted range.